Mineral metabolism and mortality in dialysis patients: A reassessment of the K/DOQI guideline

Blood Purification

Volumn 26, Issue 3, 2008, Pages 231-237

  Noordzij, Marlies ^a   Korevaar, Johanna C ^a   Dekker, Friedo W ^b   Boeschoten, Elisabeth W ^c   Bos, Willem J ^d   Krediet, Raymond T ^a   Bossuyt, Patrick M ^a   Geskus, Ronald B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Hans Mak Institute   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Calcium; Dialysis; Guidelines; Mineral metabolism; Mortality; Phosphorus

Indexed keywords

CALCIUM; PHOSPHORUS;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MORTALITY; MULTICENTER STUDY; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BONE AND BONES; CALCIUM; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NETHERLANDS; PARATHYROID HORMONE; PERITONEAL DIALYSIS; PHOSPHORUS; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK; SERUM ALBUMIN;

EID: 44349120670     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118847     Document Type: Article

References (19)

1. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003;42:S1-S202.
2. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT: The K/DOQI guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 2005;46:925-932.
3. Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA: Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant 2006;21:1663-1668.
4. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44:34-38.
5. Qunibi WY, Nolan CR: Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study. Kidney Int Suppl 2004;90:S33-S38.
6. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
7. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
8. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12:2131-2138.
9. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005;67:1179-1187.
10. Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT: Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 2006;21:2513-2520.
11. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780.
12. van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD: Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001;16:1120-1129.
13. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI: Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995;26:353-361.
14. Visser R, Dekker FW, Boeschoten EW, Stevens P, Krediet RT: Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial 1999;15:222-225.
15. Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27-39.
16. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-1213.
17. Portale AA: Blood calcium, phosphorus, and magnesium; in Favus MJ (ed): Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism, ed 4. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 115-118.
18. Harrell FE Jr, Lee KL, Pollock BG: Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1198-1202.
19. Steenland K, Deddens JA: A practical guide to dose-response analyses and risk assessment in occupational epidemiology. Epidemiology 2004;15:63-70.